Your browser doesn't support javascript.
loading
Model-Based Characterization of the Bidirectional Interaction Between Pharmacokinetics and Tumor Growth Dynamics in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab.
Grisic, Ana-Marija; Xiong, Wenyuan; Tanneau, Lénaïg; Jönsson, Siv; Friberg, Lena E; Karlsson, Mats O; Dai, Haiqing; Zheng, Jenny; Girard, Pascal; Khandelwal, Akash.
Affiliation
  • Grisic AM; the healthcare business of Merck KGaA, Darmstadt, Germany.
  • Xiong W; Merck Institute of Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany.
  • Tanneau L; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Jönsson S; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Friberg LE; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Karlsson MO; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Dai H; EMD Serono, Billerica, Massachusetts.
  • Zheng J; Pfizer, Inc., La Jolla, California.
  • Girard P; Merck Institute of Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany.
  • Khandelwal A; the healthcare business of Merck KGaA, Darmstadt, Germany.
Clin Cancer Res ; 28(7): 1363-1371, 2022 04 01.
Article in En | MEDLINE | ID: mdl-34921021

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Merkel Cell Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Merkel Cell Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United States